Dr. Carol J Fabian, MD
Claim this profileUniversity of Kansas Cancer Center
Studies Breast Cancer
Studies Lobular Carcinoma in Situ
7 reported clinical trials
7 drugs studied
Area of expertise
1Breast Cancer
BRCA1 positive
BRCA2 positive
2Lobular Carcinoma In Situ
BRCA1 positive
BRCA2 positive
Affiliated Hospitals
Clinical Trials Carol J Fabian, MD is currently running
Tamoxifen
for Breast Cancer Risk Reduction
This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Increasing breast density is a well established risk factor for breast cancer. Tamoxifen is a selective estrogen receptor modulator. It works by blocking the effects of the hormone estrogen in the breast. Tamoxifen has been shown to reduce breast density, even at reduced dosages, and is approved for the prevention of breast cancer.
Recruiting1 award Phase 2
Acolbifene vs. Tamoxifen
for Breast Cancer Prevention
This trial is testing two pills, acolbifene and low dose tamoxifen, to prevent breast cancer in premenopausal women at high risk. These women are chosen because they have a much higher chance of developing breast cancer. The drugs work by blocking estrogen, which can help stop the growth of cancer cells. Acolbifene is being assessed for breast cancer prevention, while tamoxifen has been widely studied and used for reducing breast cancer risk.
Recruiting1 award Phase 216 criteria
More about Carol J Fabian, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Carol J Fabian, MD has experience with
- Tamoxifen
- Bazedoxifene
- Conjugated Estrogens
- Acolbifene Hydrochloride
- Metformin Hydrochloride
- Placebo
Breakdown of trials Carol J Fabian, MD has run
Breast Cancer
Lobular Carcinoma in Situ
Cancer
Vulval Intraepithelial Neoplasia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Carol J Fabian, MD specialize in?
Carol J Fabian, MD focuses on Breast Cancer and Lobular Carcinoma in Situ. In particular, much of their work with Breast Cancer has involved BRCA1 positive patients, or patients who are BRCA2 positive.
Is Carol J Fabian, MD currently recruiting for clinical trials?
Yes, Carol J Fabian, MD is currently recruiting for 3 clinical trials in Kansas City Kansas. If you're interested in participating, you should apply.
Are there any treatments that Carol J Fabian, MD has studied deeply?
Yes, Carol J Fabian, MD has studied treatments such as Tamoxifen, Bazedoxifene, Conjugated Estrogens.
What is the best way to schedule an appointment with Carol J Fabian, MD?
Apply for one of the trials that Carol J Fabian, MD is conducting.
What is the office address of Carol J Fabian, MD?
The office of Carol J Fabian, MD is located at: University of Kansas Cancer Center, Kansas City, Kansas 66160 United States. This is the address for their practice at the University of Kansas Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.